Ilana Solomon, ScM, MA, CGC

Manager, Precision Medicine Program, Genetic Counselor

City of Hope

Ilana Solomon, ScM, MA, is a Manager of the Precision Medicine Program and a licensed board-certified genetic counselor specializing in cancer genetics. She received her Master’s degree Genetic Counseling from the Johns Hopkins/National Human Genome Research Institute. Ilana joined the City of Hope Division of Clinical Cancer Genomics in 2013, where she has provided cancer genetics services for patients and families suspected to have a hereditary predisposition to cancer. Since 2019 she also manages and develops City of Hope’s Precision Medicine Program, with the goal of providing all City of Hope patients with genomic-driven care. She has research interests in healthcare communication and implementation, genetic literacy, and ELSI in genomics. She helped co-develop Helping Oncology Patients Explore (HOPE) Genomics: a patient-directed IT platform for cancer genome sequencing education and return of results. She is faculty for the City of Hope Intensive Course in Genetic Cancer Risk Assessment. She is an active member of the National Society of Genetic Counselors and Southern California Genetic Counselors.

Susan Shehayeb, MS, CGC

Senior Genetic Counselor

City of Hope

SUSAN SHEHAYEB, MS, CGC, is a licensed board-certified genetic counselor specializing in cancer genetics with the Division of Clinical Cancer Genomics at City of Hope National Medical Center. She is fluent in Arabic and has competency in Spanish. She has a Master of Science degree in genetic counseling from University of California Irvine. Ms. Shehayeb's clinical role has centered on widening patient access to genetic counseling and testing throughout the City of Hope network and on genetics representation and expertise in the setting of gynecologic oncology. Her past research has focused on lifestyle choices in the context of hereditary cancer testing, hereditary causes of multiple breast cancers, and hereditary gynecologic cancers. Her special interests include hereditary gynecologic cancers and hereditary genodermatoses, furthering education of providers in the setting of genomic cancer risk assessment, and advocacy for diversity and equity in the field of cancer genetics. She is a faculty member of the City of Hope Intensive Course in Genetic Cancer Risk Assessment, and a member of the National Society of Genetic Counselors and the Southern California Genetic Counselors.

Jeffrey Weitzel, MD

Professor of Oncology and Population Sciences

Jeffrey N. Weitzel, MD, is board Certified in Medical Oncology and Clinical Genetics, and founded the Clinical Cancer Genomics Community Research Network. He co-founded the Clinical Cancer Genomics Community of Practice with Dr. Blazer. A Breast Cancer Research Foundation Scholar and an honorary Professor of Oncology for the Latin American School of Oncology, he is also the ASCO Conquer Cancer Research Professor in Breast Cancer Disparities. At the vanguard of precision prevention, Dr. Weitzel’s multidisciplinary clinical, research, and training experience emphasize translational research in cancer disparities, genomic cancer risk assessment, chemoprevention, targeted therapy, clinical and psychosocial outcomes, genetic epidemiology and health services research, with a focus on underserved populations. Dr. Weitzel received the American Society of Human Genetics Arno Motulsky-Barton Childs Award for Excellence in Human Genetics Education.

Components visible upon registration.